InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the complete record of transactions filed by Kendall Keith J, Chairman & CEO. Insider active across 1 company, notably Aquestive Therapeutics, Inc.. Aggregated, 1 filings have been recorded. Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Keith J. Kendall is the Chief Executive Officer of Aquestive Therapeutics, Inc. He leads the company with a strategic vision focused on innovation and product quality. His leadership is essential for the growth and competitiveness of the organization.